Period:
Draw Mode:
| Volume | 142,963 |
|
|||||
| News | - | ||||||
| Day High | 0.6972 | Low High |
|||||
| Day Low | 0.6523 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Passage Bio Inc | PASG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0023 | -0.35% | 0.6597 | 16:02:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.6888 | 0.6523 | 0.6972 | 0.6597 | 0.662 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 437 | 142,963 | $ 0.6729926 | $ 96,213 | - | 0.6511 - 1.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 2,275 | $ 0.658 | USD |
Passage Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 36.16M | 54.81M | - | 0 | -136.13M | -2.48 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Passage Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PASG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6914 | 0.6998 | 0.6511 | 0.6710136 | 154,804 | -0.0317 | -4.58% |
| 1 Month | 0.7839 | 0.8144 | 0.6511 | 0.7190367 | 152,261 | -0.1242 | -15.84% |
| 3 Months | 0.91 | 1.05 | 0.6511 | 0.8178294 | 177,054 | -0.2503 | -27.51% |
| 6 Months | 1.00 | 1.25 | 0.6511 | 0.9042434 | 217,320 | -0.3403 | -34.03% |
| 1 Year | 1.32 | 1.92 | 0.6511 | 1.10 | 206,547 | -0.6603 | -50.02% |
| 3 Years | 13.40 | 30.87 | 0.6511 | 8.28 | 308,233 | -12.74 | -95.08% |
| 5 Years | 22.27 | 38.23 | 0.6511 | 9.81 | 294,871 | -21.61 | -97.04% |
Passage Bio Description
| Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. |